| Wissenschaftl. Titel | A Phase I, multi-center, non-randomized, open label, drug-drug-interaction study to determine the effect of multiple doses of regorafenib (BAY 73-4506) on the pharmacokinetics of probe substrates of transport proteins P-gp (digoxin; Group A) and BCRP (sulfasalazine; Group B) in patients with advanced solid malignant tumors |
| Erkrankung | |
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 16.04.2014 Johannes Kraus
geändert 17.02.2022 Student Studienregister